Faculty Information   
   日本語 >>
  1. TOP page
    2. >
  2. Clinical Medicine Seminars
    3. >
  3. Thoracic Oncology

Journal
Presentation
    （Last updated : 2022-11-16 10:59:37）
  Matsumoto Seiji
   Department   Specialty Division  , Clinical Medicine Seminars
   Specialty Division  Thoracic Oncology, Clinical Medicine Seminars
   Position  
■ Journal
1. Original article　 Significant increase in circulating tumour cells in pulmonary venous blood during surgical manipulation in patients with primary lung cancer. 2014/06
2. Original article　 Circulating tumor cells (CTCs) in malignant pleural mesothelioma (MPM). 2014/12
3. Case report　 Gene Mutation Analysis in Determining Late Recurrence of Adenocarcinoma of the Lung. 2015/08
4. Original article　 Pravastatin reduces radiation-induced damage in normal tissues. 2017/05
5. Original article　 Positive correlation between postoperative tumor recurrence and changes in circulating tumor cell counts in pulmonary venous blood (pvCTC) during surgical manipulation in non-small cell lung cancer. 2018/01
6. Original article　 The clinical value of circulating tumour cells (CTCs) in patients undergoing pulmonary metastasectomy for metastatic colorectal cancer. 2018/03
7. Original article　 Surgical Risk and Survival Associated With Less Invasive Surgery for Malignant Pleural Mesothelioma. 2019/01
8. Original article　 The mTOR Signaling Pathway Is Associated With the Prognosis of Malignant Pleural Mesothelioma After Multimodality Therapy. 2019/11
9. Original article　 Quality of life and lung function after pleurectomy/decortication for malignant pleural mesothelioma. 2021/10
10. Original article　 Incidence and Risk Factors of Chest Wall Metastasis at Biopsy Sites in Patients with Malignant Pleural Mesothelioma. 2022/09
Display 5 items
Display all(10)
■ Presentation
1. Less invasive techniques and learning curve effects improve the outcome after extrapleural pneumonectomy for malignant pleural mesothelioma  2013/05
2. Combination efficacy of m TOR and MEK inhibitor in malignant pleural mesothelioma(MPM)  2013/05/31
3. Significant increase in circulating tumour cells in pulmonary venous blood during surgical manipulation in patients with primary lung cancer  2013/10/07
4. Activation of mTOR signal pathway is associated with prolonged survival in malignant pleural mesothelioma patients  2013/10/28
5. Association of activation of mTOR and MAPK signal pathway is associated with prolonged survival in parient with malignant pleural mesothelioma  2014/05/30
6. Blood tests in malignant pleural mesothelioma (MPM).  2014/05/30
7. Post-recurrence additional chemotherapy is feasible and effective in patients undergoing extrapleural pneumonectomy for malignant pleural mesothelioma  2014/09/29
8. Diagnostic total parietal pleurectomy for pathologically-undetermined radiological/thoracoscopis TO malignant pleural mesothelioma.  2014/10/22
9. Early results of consecutive 27 patients who underwent pleurectomy / decortication for malignant pleutral mesothelioma  2014/10/22
10. Postoperative chemotherapy after pleurectomy/decortication for malignant pleural mesothelioma  2014/10/22
11. The incidence and risk factors of part site seeding in MPM patients undergoing radical surgery  2014/10/22
12. Small cell mesothelioma undergone multimodality therapy, report of a case  2014/10/23
13. Induction Chemotherapy Followed by Surgery for Malignant Pleural Mesothelioma  2016/05/03
14. The Analysis of the Recurrence of the Patients Who Underwent Surgical Resection for Malignant Pleural Mesothelioma  2016/05/03
Display 5 items
Display all(14)
mail